glp 1 transformation GLP-1 Weight Loss Injections Transformation Tuesday This is what

1C, white area), potentially indicating a lack of response to drug treatment

GLP 1 receptor agonists and dual incretin therapies are delivering measurable, outcome driven results: 12% to 27% relative risk reduction in major adverse cardiovascular events across CVOTs 13% to 14% reduction in cardiovascular death in meta analyses 11% to 14% reduction in hospitalization for heart failure 24% relative risk reduction in kidney outcomes in the dedicated FLOW trial with semaglutide Up to 15.8% weight loss with semaglutide 2.4 mg 20.2% weight loss with tirzepatide 15 mg in head to head obesity trials 66% to 93% reduction in progression from prediabetes to type 2 diabetes This is no longer about glucose (or weight loss) alone

GLP-1s have become a cultural flashpoint on X X is hosting a fundamentally different GLP-1 conversation from Reddit though, importantly, mention volume on X accounts for lower overall SOV (16%)

Several manufacturers are also working to make GLP-1s more affordable and accessible